Post job

Xeris Pharmaceuticals overview

Industry
Pharmaceutical
Revenue
Headquarters
Employees
200
Founded in
Organization type
Public
Social media
Xeris is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. The company's proprietary XeriSol™ and XeriJect™ formulation technologies allow for the subcutaneous (SC) and intramuscular (IM) delivery of highly concentrated, non-aqueous, ready-to-use formulations of peptides, proteins, antibodies and small molecules using syringes, auto-injectors, multi-dose pens and infusion pumps. Xeris' platforms have the potential to offer distinct advantages over existing formulations of marketed and development-stage products. In particular, XeriSol™ and XeriJect™ offer the opportunity to eliminate reconstitution, enable long-term room temperature stability, significantly reduce injection volume, and eliminate the requirement for intravenous (IV) infusion. These attributes can lead to products that are easier to use by patients, caregivers, and health practitioners and reduce costs for payers and the healthcare system.
Xeris Pharmaceuticals is a small pharmaceutical company based in Chicago, IL with only 200 employees and an annual revenue of $203.1M.

Xeris Pharmaceuticals's mission statement

Xeris is dedicated to the development of ready-to-use injectable and infusible drug formulations to address important unmet medical needs and that are easier to use by patients, caregivers and health practitioners, and reduce costs for payors and the healthcare system.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Xeris Pharmaceuticals employee reviews

Be the first to review!

Do you work at Xeris Pharmaceuticals?

Help job seekers learn about working at Xeris Pharmaceuticals

Job openings at Xeris Pharmaceuticals
82 positions

On this page

Be the first to review Xeris Pharmaceuticals

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Xeris Pharmaceuticals?

The team at Xeris Pharmaceuticals

  • The founders of Xeris Pharmaceuticals are Dr. John Kinzell Ph.D. and Steven Prestrelski.
  • The key people at Xeris Pharmaceuticals are Paul R. Edick, Dr. John Kinzell Ph.D. and Steven Prestrelski.
Key people
Paul R. Edick
Dr. John Kinzell Ph.D.
Steven Prestrelski

Xeris Pharmaceuticals rankings

Xeris Pharmaceuticals is ranked #17 on the Best Pharmaceutical companies to work for in Illinois list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Rate the Xeris Pharmaceuticals' inclusivity.

Zippia waving zebra

Do you work at Xeris Pharmaceuticals?

Did Xeris Pharmaceuticals' compensation package meet your expectations?

Xeris Pharmaceuticals financial performance

7.5
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Xeris Pharmaceuticals currently has 110.2M in revenue. Xeris Pharmaceuticals's most recent quarter produced 38.0m (q2'2023).

Xeris Pharmaceuticals annual revenue

$203M
$162M
$122M
$81M
$41M
$0
2020
2021
2022
2023
2024

Are you an executive, HR leader, or brand manager at Xeris Pharmaceuticals?

Claiming and updating your company profile on Zippia is free and easy.

Xeris Pharmaceuticals FAQs

Search for jobs

Most common locations at Xeris Pharmaceuticals

Most common jobs at Xeris Pharmaceuticals

Zippia gives an in-depth look into the details of Xeris Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Xeris Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Xeris Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Xeris Pharmaceuticals. The data presented on this page does not represent the view of Xeris Pharmaceuticals and its employees or that of Zippia.

Xeris Pharmaceuticals may also be known as or be related to XERIS PHARMACEUTICALS INC, Xeris Pharmaceuticals, Xeris Pharmaceuticals Inc, Xeris Pharmaceuticals Inc. and Xeris Pharmaceuticals, Inc.